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In recent years self-measurement of blood pressure 
at home has gained increasing importance but there 
have been only a few studies comparing casual, 
ambulatory, and self-measured blood pressure deter-
minations during a single clinical trial. We there-
fore compared treatment-induced blood pressure-
reductions in a double-blind, placebo-controlled, 
parallel study design with a single morning dose of 
either 10 mg bisoprolol (n = 26) or 20 mg nitrendi-
pine (n = 27) with casual blood pressure readings 
in the morning before the dose, ambulatory 24-h 
monitoring, and self-recorded measurements in the 
morning before the dose and in the evening. 
Mean reductions for systolic and diastolic blood 
pressure after 4 weeks of therapy were signifi-
cantly greater for bisoprolol than for nitrendipine. 
The treatment-induced blood pressure reductions 
were most pronounced as assessed by casual read-
ings but showed good agreement between casual, 
ambulatory, and self-measured blood pressure for 
group comparisons. In some patients, however, 
marked individual differences between the three 
methods were observed. Correlation coefficients 
between ambulatory and self-measured blood pres-
sure were 0.4 for systolic blood pressure (P < .05) 
and 0.6 for diastolic blood pressure (P < .0005). 
Under the conditions of this parallel study design 
and the usual statistical risks, a difference of 5 mm 
Hg in diastolic blood pressure can be detected in 
118 patients at the clinic, in 70 patients if ambula-
tory blood pressure is used, or in 56 patients if self-
measured blood pressure is used. 
In conclusion, bisoprolol was more effective over 
24 h than nitrendipine at the doses studied. Fur-
thermore, self-measured blood pressure was suit-
able for monitoring 24-h efficacy of the two antihy-
pertensive drugs under investigation. Finally, 
self-measured blood pressure can substantially im-
prove the sensitivity of hypertension trials in com-
parison to casual readings and therefore reduce the 
number of patients included. Am J Hypertens 
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Accurate blood pressure measurement is es-sential for the reliable assessment of antihy-pertensive drugs. In clinical trials of antihy-pertensive drugs, casual or clinic blood 
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pressure measurement has been routinely used. In re-
cent years alternative methods of blood pressure deter-
mination, such as ambulatory 24-h monitoring and self-
measurement at home, have gained increasing 
importance for the practical management of hyperten-
sion as well as for clinical trials. 1" 3 The reliability of 
casual blood pressure measurements in determining the 
effect and duration of antihypertensive therapy may be 
limited by factors such as blood pressure variability and 
observer bias . 4 - 6 In recent years there has been growing 
awareness that different methods of determining blood 
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pressure, such as physician's measurement, ambulatory 
readings or self-measurement at home, may provide 
different information regarding blood pressure 
reduction. 7 - 8 Some suggested that, by the greater num-
ber of readings, ambulatory or self-recorded blood pres-
sure measurements reduced the inherent blood pressure 
variability and improved the precision and sensitivity of 
hypertension tr ials . 9 - 1 1 Menard et al in a recent trial 
demonstrated that self-measurement can reduce the 
number of subjects needed to detect a clinically relevant 
difference in diastolic blood pressure as compared to 
casual readings. 1 0 
The value of noninvasive ambulatory blood pressure 
monitoring in pharmacological studies now seems well 
established, but there are only limited data available on 
the usefulness of self-recorded blood pressure measure-
ments during drug t r ia l s . 2 , 4 / 8 - 1 0 , 1 3 To our knowledge 
there have been no published comparisons of the three 
different noninvasive techniques for measuring blood 
pressure during a clinical trial. 
The aim of the present study was to compare the 
blood pressure response under the cardioselective 
/?-blocker bisoprolol or the calcium-channel antagonist 
nitrendipine as observed by casual, ambulatory, and 
self-recorded blood pressure readings. The antihyper-
tensive efficacy and tolerability of both drugs have been 
proven in comparative and noncomparative studies, 
most of them using conventional clinic readings. 1 5 - 1 8 
Furthermore, we investigated whether the use of either 
ambulatory or self-recorded blood pressure measure-
ment can increase the sensitivity of such a study design 
and reduce the number of patients needed. 
METHODS 
Patients Patients with mild to moderate essential hy-
pertension were included in the study if they were be-
tween 18 and 70 years of age. Women of childbearing 
potential were excluded. Hypertension was defined as 
diastolic blood pressure ^ 9 5 mm Hg on three occasions 
during the placebo run-in period. 
There were no significant differences between the 
groups in age, body mass index, smoking history, or 
alcohol consumption at entry into the trial. 
Study Design The study design was a double-blind 
approach with two parallel, randomized groups. If the 
patients still fulfilled the entry criteria at the end of the 2 
week placebo run-in period, they proceeded to the ac-
tive treatment phase, taking either 10 mg bisoprolol or 
20 mg nitrendipine in a single morning dose for 4 weeks. 
The study was approved by the ethical committee of 
the University of Zurich. 
Blood Pressure Measurement All visits were sched-
uled between 8 and 10 AM and patients were asked not 
to take their morning medication prior to the blood 
pressure determination at the clinic on the consultation 
days. Casual blood pressure was measured after 5 min 
rest in a sitting position with a mercury sphygmoma-
nometer. The same arm was always used, according to 
the recommendations of the American Heart Associa-
tion. We used phase V of Korotkoff sounds as the dia-
stolic blood pressure. 1 9 Three readings were taken at 
days 1, 7, and 14 of the placebo period and days 1, 14, 
and 28 of the active treatment phase. The mean value of 
the last placebo day and the last treatment day was used 
for group comparisons. Pulse rate was determined after 
casual blood pressure reading. 
After the casual readings had been taken, ambulatory 
24-h blood pressure monitoring was performed during 
an average working day (day 14 of the placebo period 
and day 28 of the treatment phase) using the Spacelabs 
90202 (Redmond, WA) noninvasive automatic blood 
pressure recorder. 2 0 , 2 1 Blood pressure and heart rate 
were measured at preset 20 min intervals from 6 AM to 
12 PM and at 60 min intervals at night. Systolic, diastolic 
blood pressure, mean arterial pressure, and heart rate 
were stored in the Spacelabs monitor. Artifactual read-
ings (slow cuff inflation, measurement aborted because 
of low batteries, blood pressure not detected, pressure 
artifacts) were edited out by the Spacelabs computer 
program, as were readings below or above given limits 
(systolic blood pressure < 70 or > 260 mm Hg, diastolic 
blood pressure < 4 0 or > 1 5 0 mm Hg, pulse pressure 
< 2 0 or > 150 mm Hg, heart rate < 2 0 or > 200 beats/ 
min). The data were analyzed on an IBM (Armoak, NY) 
computer. 
After sufficient instruction in the correct self-measure-
ment technique by the physician in charge of the trial, 
each patient was directed to measure blood pressure and 
heart rate at home in the morning before medication (6 
to 8 AM) and in the evening (6 to 8 PM) and to keep a 
record of all readings. Self-measurement was per-
formed during the whole study period with a previously 
calibrated semiautomatic, manual, aneroid device with 
a microphone built into the cuff and acoustic as well as 
visual identification of Korotkoff sounds (Sysditon, 
Friedrich Bosch GmbH, Juningen, Germany). In order to 
avoid an artificial blood pressure increase due to 
squeezing the sphygmomanometer bulb, each patient 
was instructed to place the cuff on the nondominant 
arm and to use the hand of the opposite arm to inflate 
the cuff while keeping the cuff arm relaxed. 
Self-measured morning (6 to 8 AM) and evening (6 to 8 
PM) blood pressures were averaged from the 2 weeks of 
placebo and the last 2 weeks of treatment. Means were 
used for group comparisons. 
Since the comparisons of the treatment-induced 
blood pressure reductions include different numbers of 
measurement by each method, we have presented the 
results recorded by each method as group means before 
and after treatment. For each patient the change in 
blood pressure was calculated for each method of mea-
surement. These values were averaged for each method 
to obtain a mean reduction in blood pressure. 
Results are expressed as mean ± SEM. The unpaired t 
test was used to compare the interindividual changes in 
blood pressure of both antihypertensive drugs. Scatter 
plots, paired t tests, and correlation coefficients were 
used to compare the intraindividual changes in blood 
pressure obtained by the different methods of 
measurement. 
Compliance Compliance with the treatment was mea­
sured by pill-counting and regarded as adequate if more 
than 8 0 % of the prescribed pills had been taken. Pa­
tients with inadequate compliance were excluded from 
the study. 
RESULTS 
Trial Results Of the 53 patients who entered the 
study, one in each group had to be withdrawn because 
of intolerable side-effects. The remaining 51 patients 
completed the study, 25 taking bisoprolol (10 women, 
15 men, mean age 50 years, range 29 to 65) and 26 
taking nitrendipine (9 women, 17 men, mean age 48 
years, range 22 to 70). 
After 2 weeks of placebo there were no significant 
differences in the blood pressure values between the 
bisoprolol and nitrendipine groups as assessed by casual 
(150/100 ν 155/102 mm Hg), ambulatory daytime 
blood pressure (149/96 ν 150/97 mm Hg), ambulatory 
night-time blood pressure (133/82 ν 138/86 mm Hg) 
and self-recorded blood pressure (146 /97z ;146 /97 mm 
Hg). 
Changes in Blood Pressure: Bisoprolol ν Nitrendipine 
Mean changes in blood pressure after 4 weeks of active 
treatment with bisoprolol or nitrendipine are given in 
Figures 1 and 2. With casual readings in the clinic the 
blood pressure reduction appeared to be more pro­
nounced under bisoprolol ( 1 4 ± 2 . 4 / 1 3 ± 1 . 8 mm Hg) 
as compared to nitrendipine (7.3 ± 2 .7 /6 ± 2 mm Hg), 
but this difference was significant only for diastolic 
values (P = .01). 
Ambulatory daytime (8AM to 8 PM) and nighttime re­
cordings (8 PM to 8 AM) showed a greater blood pressure 
response under bisoprolol than under nitrendipine. The 
observed differences were however only significant for 
the nighttime period (11.6 ± 2 .9/8.6 ± 1 . 7 mm Hg ν 
3.1 ± 2.3/1.4 ± 1.7 mmHg). The minor blood pressure 
lowering effect of the calcium channel antagonist of 3 / 1 
mm Hg 12 to 24 h after the dose was not significant as 
compared to the placebo period (P > .5). 
With self-recorded measurements a reduction of 
10.9 ± 2 .8/10.7 ± 1.8 mm Hg was observed in the pa­
tients treated with bisoprolol. The /^-blocker thus was 
more effective than the calcium channel antagonist, 
which lowered blood pressure only by 3.4 ± 1.5/3 ± 1 
mm Hg. 
Methodological Observations Comparison of Casual, 
Ambulatory, and Self-Measured Blood Pressure Determina­
tions In order to investigate whether either casual or 
self-measured blood pressure was useful to evaluate 
24-h antihypertensive efficacy of the two drugs, we 
compared the treatment-induced blood pressure reduc­
tions as assessed by the two techniques with those ob­
tained by 24-h whole-day blood pressure monitoring. 
A group comparison of the respective blood pressure 
changes demonstrated that in both treatment groups the 
clinical readings showed the greatest reduction, al­
though the observed differences in comparison to ambu­
latory or self-recorded readings did not reach statistical 
significance (Table 1). 
Scatter plots of the individual diastolic blood pressure 
changes recorded by casual, ambulatory, and self-mea­
sured readings are shown in Figure 3 and 4. Correlation 
coefficients were 0.6 (P < .0005) between ambulatory 
and self-measured blood pressure and 0.4 between am­
bulatory and casual readings (P < .05). The respective 
values for the systolic recordings were 0.4 for self-mea­
surement and 0.48 for clinic readings (P < .05). How­
ever, when the statistical method discussed by Bland 
and Altman for assessing agreement between the dif­
ferent methods of blood pressure determination was 
used, the estimated limits of agreement were very wide. 
A comparison of the blood pressure (BP) changes 
measured by casual and by ambulatory readings demon­
strated for the systolic values a mean difference of 
1.5 ± 1 2 . 7 mm Hg (casual BP - ambulatory BP, 
mean ± SD) with a 9 5 % confidence interval of — 2.1 to 
+ 5.2 and for the diastolic values a mean difference of 
2.8 ± 9 . 9 mm Hg (casual BP - ambulatory BP; 
mean ± SD) with a 9 5 % confidence interval of 0.001 to 
+ 5.7. 
A comparison of the respective blood pressure 
changes as assessed by self-measured and ambula­
tory readings showed for the systolic values a mean 
difference of —1.8 ± 1 2 . 2 mm Hg (self-measured 
BP - ambulatory BP; mean ± SD) with a 9 5 % confi­
dence interval of —5.6 to + 2 . 0 and for the diastolic 
values a mean difference of 0.5 ± 7 . 1 mm Hg (self-
measured BP — ambulatory BP, mean ± SD) with a 
9 5 % confidence interval of - 1 . 7 to + 2 . 7 . 
Sensitivity of the Trial The sensitivity of the study de­
sign is described by the statistical power achieved with a 
given number of patients or by the number of patients 
needed to detect with a given statistical power a clini­
cally significant blood pressure difference. 2 3 At a two-
sided a risk of 5 % and a statistical power of 80%, a 
diastolic difference of 5 mm Hg would require 118 pa­
tients with the use of casual readings, 70 with ambula­
tory monitoring, or 56 with self-measurement (Table 2). 
Similarly, the number of patients needed to detect a 
systolic difference of 10 mm Hg can be nearly halved by 
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Clinic ABPM ABPM 8am-8pm 8pm-8am SMBP 
Bisoprolol 
^ Nitrendipine 
FIGURE 1. Mean change (± SEM) in 
systolic blood pressure after 4 weeks of 
treatment with either bisoprolol or ni­
trendipine as assessed by casual, ambu­
latory (ABPM), and self-measured 
blood pressure (SMBP). * Ρ < .05. 
the use of self-measurement rather than clinic readings 
(Table 2). 
DISCUSSION 
In the present study the antihypertensive efficacy of 
nitrendipine ν bisoprolol after a single morning dose 
were compared, using three different methods of blood 
pressure determination. Recent studies comparing con­
tinuous ambulatory recordings of blood pressure with 
casual or self-measured readings have drawn attention 
to the fact that different methods of measuring blood 
pressure can provide different results. These observa­
tions have renewed interest in the methodological 
aspects of antihypertensive trials, which were a major 
focus of the present study. 
Casual blood pressures were taken in the morning 
before medication in order to assess antihypertensive 
effect 24 h postdosage. Both drugs induced significant 
reductions in casual systolic and diastolic blood pressure 
after 4 weeks of treatment as described in other 
Clinic ABPM 8am-8pm 
ABPM 
8pm-8am SMBP 
Bisoprolol 
^ Nitrendipine 
FIGURE 2. Mean change (± SEM) in 
diastolic blood pressure after 4 weeks 
treatment with either bisoprolol or ni­
trendipine as assessed by casual, ambu­
latory (ABPM), and self-measured 
(SMBP) blood pressure. * P < . 0 5 ; 
**P<.005. 
TABLE 1. CHANGE IN SYSTOLIC (SBP) AND DIASTOLIC BLOOD PRESSURE (DBP) AND COMPARISON 
OF CHANGES RECORDED BY CASUAL, AMBULATORY (ABPM), OR SELF-MEASUREMENT (SMBP) AFTER 
4 WEEKS TREATMENT WITH BISOPROLOL OR NITRENDIPINE 
BP Reduction Casual ABPM SMBP 
Bisoprolol 
SBP 14.0 ± 2 . 4 NS 11.8 ± 2 . 5 NS 10.9 ± 2 . 8 
DBP 13.0 ± 1.8 NS 9.2 ± 1.2 NS 10.7 ± 1.8 
Nitrendipine 
SBP 7.3 ± 2 . 7 NS 5.6 ± 2 . 3 NS 3.4 ± 1.5 
DBP 6.0 ± 2 . 0 NS 3.4 ± 1.7 NS 3.0 ± 1.0 
Values are mean ± SEM. The mean change in blood pressure, as recorded by each method of measurement in each patient, was compared using a 
two-tailed Student's paired t test. 
studies. 1 5 " 1 8 Although the casual blood pressure values 
achieved with bisoprolol were lower than those 
achieved with nitrendipine, this difference was signifi­
cant only for the diastolic blood pressure reductions. 
Similarly, the ambulatory daytime (8 AM to 8 PM) blood 
pressure values demonstrated significant systolic and 
diastolic reductions induced by both drugs. The blood 
pressure response with the /?-blocker was more pro­
nounced than the response with the calcium-channel 
antagonist but did not reach statistical significance. 
The ambulatory nighttime (8 PM to 8 AM) monitoring, 
however, showed that bisoprolol was significantly more 
effective than nitrendipine, which did not appear to be 
effective over 24 h after a single morning dose. Thus our 
results confirm the findings of recent trials with nitren­
dipine using ambulatory blood pressure monitoring. In 
these studies no significant effect on the early morning 
blood pressure rise was demonstrated. 1 7 , 1 8 The self-
measured blood pressure values, obtained near the end 
of the dosing interval, followed a similar trend, docu­
menting a significantly more pronounced fall in systolic 
and diastolic blood pressure with the /^-blocker. 
In addition our results suggest that the analysis of two 
different time periods of whole-day ambulatory blood 
pressure monitoring, ie, daytime and nighttime values, 
as well as that of the self-measured blood pressure 
values, may be superior to casual measurements in eval­
uating the 24-h blood pressure control of two antihy­
pertensive agents with different durations of action. 
In both treatment groups systolic and diastolic blood 
pressure reductions tended to be more pronounced with 
casual measurements than with either ambulatory 
monitoring or self-measurement, although the differ­
ence was not significant. The lack of a significant differ­
ence between the methods differs from other studies 
demonstrating under- as well as overestimates of the 
overall blood pressure decrement by conventional read­
ings . 8 , 1 3 , 2 4 In a verapamil study, Gould et al observed a 
FIGURE 3. Scatter plot of change 
in mean diastolic blood pressure (mm 
Hg) recorded by ambulatory whole-
day monitoring ν self-measured 
blood pressure. 
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FIGURE 4. Scatter plot of change 
in mean diastolic pressure (mm Hg) 
recorded by ambulatory whole-day 
monitoring ν casual blood pressure. 
significantly greater mean reduction of the clinic systolic 
blood pressure compared with either intraarterial or 
self-recorded pressure. They suggested that overesti­
mates in casual measurements may result from the lack 
of a placebo control.8 Other authors observed that ca­
sual blood pressure, measured near the end of the dos­
ing interval, tends to underestimate overall drug effi­
cacy. 2 4 Gordon et al measured the blood pressure 
reduction in response to a thiazide diuretic, using both 
casual and self-recorded measurements. 1 3 Their find­
ings differ from ours hi that the clinic systolic blood 
pressure determinations indicated a smaller reduction 
than did the self-measured blood pressures. 
The correlation coefficients for the change in blood 
pressure between ambulatory monitoring and self-
measurement were higher than recently reported by an­
other group.8 These discrepancies may be explained by 
the use of different devices for measuring ambulatory 
and self-recorded blood pressure. In the present study 
TABLE 2. SENSITIVITY OF THE STUDY DESIGN 
WITH CASUAL, AMBULATORY (ABPM), OR SELF-
MEASURED BLOOD PRESSURE (SMBP) 
DETERMINATIONS 
Number of Patients 
Method Systolic Diastolic 
Casual 55 118 
ABPM 44 70 
SMBP 31 56 
Number of patients needed to detect at a two-sided a risk of 5% and a 
statistical power of 80% a systolic blood pressure difference of 10 mm Hg 
and a diastolic difference of 5 mm Hg.23 
self-measurement was performed with a semiautomatic 
device without stethoscope, avoiding the difficulties in 
identifying Korotkoff phase V as diastolic blood pres­
sure. Thus, in our hypertension trial self-recorded blood 
pressure measurement at home appears to give valid 
results when used to estimate the antihypertensive ef­
fect of drugs. 
When the statistical method discussed by Bland and 
Altman 2 2 for assessing agreement between the different 
methods of blood pressure determination was used, a 
similar limit of agreement of casual and self-measured 
readings as compared to ambulatory readings was dem­
onstrated for the systolic blood pressure values. 
For the diastolic blood pressures the agreement be­
tween self-measurement and ambulatory monitoring 
was distinctly superior to the agreement between self 
measurement and the casual readings. However, in 
some patients marked intraindividual variations be­
tween the three different methods of blood pressure 
determination were observed. 
Another interesting finding emerging from the 
present study was the observation that the use of self-
measurement can substantially improve the sensitivity 
of the trial. Similarly, in a previous study Menard et al 
observed that a difference of 5 mm Hg in diastolic blood 
pressure could be detected in 27 patients using casual 
blood pressure determinations or in 20 patients using 
self-measurement. 1 0 The seeming discrepancy between 
the data in our study and those of Menard, in determin­
ing the number of patients required to obtain clinically 
relevant results using the different forms of blood pres­
sure measurement can be explained by the use of a 
different study design. Thus, in the present study a par-
allel approach was chosen, whereas Menard et al used a 
crossover design, which substantially improves the sen­
sitivity of the trial. 2 5 This information is useful for the 
future planning of studies to test antihypertensive 
drugs. The number of patients necessary for a trial is 
dependent on the expected difference in blood pressure 
and the observed variability. Generally to halve the vari­
ability, ie, the standard deviation of the mean difference 
between readings, will double the precision of the trial. 
In conclusion, our results indicate that bisoprolol was 
more effective over 24 h than nitrendipine at the doses 
studied. Furthermore, the analysis of ambulatory day-
and nighttime values as well as that of self-measured 
blood pressure values were superior to casual readings 
for monitoring 24-h efficacy of the two antihyperten­
sive drugs under investigation. Finally self-recorded 
blood pressure measurements can substantially im­
prove the sensitivity of a parallel study design by halv­
ing the number of patients needed to detect clinically 
significant differences in blood pressure control. 
ACKNOWLEDGEMENTS 
We wish to thank Miss Buschmann-Deckels for support of the 
study and Mrs. L. Sahli (E. Merck AG) for excellent secretarial 
assistance. 
REFERENCES 
1. World Hypertension League: Self-measurement of 
blood pressure. J Hypertens 1988;6:257-261. 
2. Weisser B, Mengden T, Vetter W: Ambulatory twenty-
four-hour blood pressure measurement in pharmacologi­
cal studies. J Hypertens 1991;8(suppl 6):87-92. 
3. Mengden T, Battig B, Vetter W: Self-monitoring of blood 
pressure. J Hum Hypertens 1990;4(suppl I):47-50. 
4. White BW: Methods of blood pressure determination to 
assess antihypertensive agents: are casual measurements 
enough? Clin Pharmacol Therap 1989;45:581-586. 
5. Weber MA, Cheung DG, Graettinger WF, Lipson JL: 
Characterization of antihypertensive therapy by whole-
day blood pressure monitoring. JAMA 1988;259:3281-
3285. 
6. Steiner A, Oertel R, Battig B, et al: Effect of fish oil on 
blood pressure and serum lipids in hypertension and 
hyperlipidaemia. J Hypertens 1989;7(suppl 3):73-76. 
7. Waeber B, Petrillo A, Scherrer U, et al: Are some hyper­
tensive patients overtreated. A prospective study on am­
bulatory blood pressure recording. Lancet 1987;ii:732-
734. 
8. Gould Β A, Homung RS, Kieso H, et al: An evaluation of 
self-recorded blood pressure during drug trials. Hyper­
tension 1986;8:267-271. 
9. Cottier C, Julius S, Gajendragadkar SV, Shork A: Useful­
ness of home blood pressure determination in treating 
borderline hypertension. JAMA 1982;248:555-558. 
10. Menard J, Serrurier D, Bautier P, et al: Crossover design 
to test antihypertensive drugs with self-recorded blood 
pressure. Hypertension 1988;11:153-159. 
11. Conway J, Coats A, Radaelli AJS: Ambulatory blood 
pressure in relation to drug treatment and clinical trials. J 
Hypertens 1990;8(suppl 6):83-85. 
12. Coats AJS: Reproducibility or variability of casual and 
ambulatory blood pressure data: implications for clinical 
trials. J Hypertens 1990;8(suppl 6): 17-20. 
13. Gordon RD, Pawskey GK, O'Halloran MW, et al: Use of 
home blood pressure measurement to compare the effi­
cacy of two diuretics. Med J Aust 1972;2:565-570. 
14. Goa KL: Nitrendipine. A review of its pharmacodynamic 
and pharmacokinetic properties, and therapeutic effi­
cacy in the treatment of hypertension. Drugs 
1987;33:123-155. 
15. Lancaster SG, Sorkin EM: Bisoprolol: a preliminary re­
view of its pharmacodynamic and pharmacokinetic prop­
erties, and therapeutic efficacy in hypertension and an­
gina pectoris. Drugs 1988;36:256-285. 
16. Weiner L, Fritz G: Antihypertensive effect of bisoprolol 
during once daily administration in patients with essen­
tial hypertension. A dose-ranging study with parallel 
groups. Eur J Clin Pharmacol 1986;29:517-521. 
17. Heagerty AM, Swales JD: A double-blind randomized 
cross-over study of the efficacy and tolerability of nifedi­
pine and nitrendipine in the treatment of mild to moder­
ate hypertension. Br J Clin Pharmac 1989;27:411-416. 
18. Groth H, Stimpel M, Edmonds D, et al: Nitrendipine, a 
new calcium antagonist, as first-choice treatment in es­
sential hypertension. Schweiz Rundsch Med Prax 
1985;74:503-506. 
19. Kirkendall WM, Feinlieb M, Freis ED, Mark AL: Recom­
mendation for human blood pressure determinations by 
sphygmomanometers. Circulation 1980;62:1146A-
1155A. 
20. O'Brien E, Sheridan J, Browne T, et al: An evaluation of 
the Spacelabs 90202 non-invasive ambulatory blood 
pressure recorder. J Hypertens 1989;7(suppl 6):S388-
S389. 
21. Graettinger WF, Lipson JL, Cheung DJ: Validation of 
oscillometric, auscultatory and r-wave gated ausculta­
tory automated portable blood pressure measurements 
by intra-arterial line and sphygmomanometer. Am Heart 
J 1988;116:1155-1160. 
22. Bland JM, Airman DG: Statistical methods for assessing 
agreement between two methods of clinical measure­
ment. Lancet 1986;i:307-311. 
23. Altman DG: Statistics and ethics in medical research. III. 
How large a sample? Br Med J 1980;281:1336-1338. 
24. Weber MA, Tonkon MJ, Klein RG: Blood pressure moni­
toring for assessing the duration of action of antihyper­
tensive treatment. J Clin Pharmacol 1987;27:751-755. 
25. Hills M, Armitage P: The two-period cross-over clinical 
trial. Br J Clin Pharmacol 1979;8:7-20. 
